Mechanism by which alcohol and wine polyphenols affect coronary heart disease risk

Francois M Booyse1, Wensheng Pan, Hernan E Grenett

  • 1University of Alabama at Birmingham, Birmingham, AL 35294-2170, USA.

Insights

Moderate alcohol and polyphenol intake enhances fibrinolysis, reducing coronary heart disease risks. This study details how these compounds increase blood clot lysis by modulating endothelial cell function.

Area of Science:

  • Cardiovascular Science
  • Molecular Biology
  • Pharmacology

Background:

  • Moderate alcohol consumption is linked to reduced coronary heart disease (CHD), potentially via enhanced fibrinolysis.
  • Endothelial cell (EC)-mediated fibrinolysis is crucial for mitigating acute atherothrombotic events like myocardial infarction (MI).
  • Alcohol and polyphenols influence EC fibrinolytic protein expression, impacting overall fibrinolytic activity.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which alcohol and polyphenols increase EC tissue plasminogen activator (t-PA) expression.
  • To investigate the impact of alcohol and polyphenol treatment on in vitro and in vivo fibrinolysis.
  • To assess the therapeutic potential of alcohol, catechins, and quercetin in normalizing impaired clot lysis in an atherosclerosis model.

Main Methods:

  • Analysis of EC fibrinolytic protein expression (t-PA, u-PA, PAI-1, u-PAR, Annexin-II) at cellular, molecular, and gene levels.
  • Investigation of p38 MAPK signaling pathway activation.
  • In vivo studies using real-time fluorescence imaging of Cy5.5-labeled fibrin clot lysis in C56Bl/6 and ApoE knock-out mice.

Main Results:

  • Alcohol and polyphenols (catechins, quercetin) significantly increase EC t-PA gene transcription and subsequent fibrinolytic activity.
  • In vivo studies demonstrated significantly increased clot lysis rates in mice treated with alcohol, catechins, or quercetin.
  • Treatment with alcohol, catechins, or quercetin normalized impaired in vivo clot lysis in ApoE knock-out mice, suggesting atheroprotective effects.

Conclusions:

  • Alcohol and specific polyphenols enhance endothelial fibrinolytic capacity through p38 MAPK signaling, leading to increased clot lysis.
  • These findings provide a molecular basis for the cardioprotective effects of moderate alcohol and polyphenol consumption.
  • Alcohol, catechins, and quercetin show potential for therapeutic intervention in conditions with impaired fibrinolysis, such as atherosclerosis.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Oxidation of Phenols to Quinones01:17

Oxidation of Phenols to Quinones

In the presence of oxidizing agents, phenols are oxidized to quinones. Quinones can be easily reduced back to phenols using mild reducing agents. The electron-donating hydroxyl group enhances the reactivity of the aromatic ring, enabling oxidation of the ring even in the absence of an α hydrogen.
o-hydroxy phenols are oxidized to o-quinones and p-hydroxy phenols to p-quinones. Such redox reactions involve the transfer of two electrons and two protons. The reversible redox property is crucial in...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...